A photo of Chet Villa.

Pediatric Cardiologist, Heart Failure & Transplantation

Associate Professor, UC Department of Pediatrics



Board Certified

About Me


Children with severe heart disease once had few clinical options. While we’ve made many advances, it’s still critical that we improve therapeutic options and develop new approaches.

At Cincinnati Children’s, I care for children with complex medical needs and severe heart disease. This includes children with Duchenne muscular dystrophy, RASopathies, and those in need of ventricular assist device therapy and heart transplant.

My research is focused on finding ways to provide care to children and young adults with heart disease who have limited access to advanced therapies.

Clinical Interests

Advanced heart failure; heart transplantation; cardiomyopathy; mechanical circulatory support

Research Interests

Ventricular assist device therapy; Duchenne muscular dystrophy

Academic Affiliation

Associate Professor, UC Department of Pediatrics

Clinical Divisions

Cardiomyopathy, Rasopathy, Cardio-Oncology, Neuromuscular Cardiology, Neuromuscular Disorders

Blog Posts

Top 5 Things to Know About the Heart in Duchenne Muscular Dystrophy

BlogHeart Conditions

Top 5 Things to Know About the Heart in Duchenne Muscular Dystrophy

By Chet Villa, MD5/30/2019

My Locations

My Education

MD: University of Cincinnati College of Medicine, Cincinnati, OH, 2007.

Residency: Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH.

Certification: American Board of Pediatrics, 2010; Pediatric Cardiology, 2014.

My Publications

A validated model for sudden cardiac death risk prediction in pediatric hypertrophic cardiomyopathy. Miron, A; Lafreniere-Roula, M; Steve Fan, C; Armstrong, KR; Dragulescu, A; Papaz, T; Manlhiot, C; Kaufman, B; Butts, RJ; Gardin, L; et al. Circulation. 2020; 142:217-229.

Optimizing Postcardiac Transplantation Outcomes in Children with Ventricular Assist Devices: How Long Should the Bridge Be?. Riggs, KW; Zafar, F; Lorts, A; Villa, CR; III, BR; Morales, DL S. ASAIO Journal. 2020; 66:787-795.

Implantable Cardioverter Defibrillator Use in Males with Duchenne Muscular Dystrophy and Severe Left Ventricular Dysfunction. McCulloch, MA; Lal, AK; Knecht, K; Butts, RJ; Villa, CR; Johnson, JN; Conway, J; Bock, MJ; Schumacher, KR; Law, SP; et al. Pediatric Cardiology. 2020; 41:925-931.

Commentary: The tortoise and the hare: Does speed matter in pediatric VAD therapy?. Villa, CR; Morales, DL S. Journal of Thoracic and Cardiovascular Surgery. 2020; 159:1528-1529.

Risk Factors for Cardiac and Non-cardiac Causes of Death in Males with Duchenne Muscular Dystrophy. Wittlieb-Weber, CA; Knecht, KR; Villa, CR; Cunningham, C; Conway, J; Bock, MJ; Gambetta, KE; Lal, AK; Schumacher, KR; Law, SP; et al. Pediatric Cardiology. 2020; 41:764-771.

The Creation of a Pediatric Health Care Learning Network: The ACTION Quality Improvement Collaborative. Lorts, A; Smyth, L; Gajarski, RJ; VanderPluym, CJ; Mehegan, M; Villa, CR; Murray, JM; Niebler, RA; Almond, CS; Thrush, P; et al. ASAIO Journal. 2020; 66:441-446.

Investigation of de novo variation in pediatric cardiomyopathy. Parrott, A; Khoury, PR; Shikany, AR; Lorts, A; Villa, CR; Miller, EM. American Journal of Medical Genetics, Part C: Seminars in Medical Genetics. 2020; 184:116-123.

The total artificial heart in pediatrics: Outcomes in an evolving field. Villa, CR; Moore, RA; Morales, DL; Lorts, A. Annals of cardiothoracic surgery. 2020; 9:104-109.

The total artificial heart in patients with congenital heart disease. Thangappan, K; Ashfaq, A; Villa, C; Morales, DL S. Annals of cardiothoracic surgery. 2020; 9:89-97.

Expanding the donor pool for congenital heart disease transplant candidates by implementing 3D imaging-derived total cardiac volumes. Shugh, SB; Szugye, NA; Zafar, F; Riggs, KW; Villa, C; Lorts, A; Morales, DL S; Moore, RA. Pediatric Transplantation. 2020; 24.